HIGHLIGHTS OF EVENT
- The State of Liver Disease in South Asia: What are we doing about it?
- Eradication of HCV: Myth or Reality
- DAA and common drug interactions.
- NAFLD related Cirrhosis in Diabetic- Therapeutic options
- Monitoring surrogates of HBV: DNA/ mRNA/ qHBsAg
- Exercise and Dietary intervention in NAFLD: How to be precise?
- Decompensated HCV Cirrhosis: Have DAAs Improved Transplant Free Survival?
Target Audience
Sixth annual meeting of the South Asian Association for the Study of the Liver (SAASL) and fist International Conference of the Nepalese Association for the Study of the Liver (NASL)
Topics For Abstracts
- The State of Liver Disease in South Asia: What are we doing about it?.
- Eradication of HCV: Myth or Reality
- DAA and common drug interactions
- NAFLD related Cirrhosis in Diabetic- Therapeutic options
CME Accreditations
The scientific program focused on latest developments in alcoholic liver diseases, hepatitis B, C, hepatocellular carcinoma etc
Topic | Presenter |
---|---|
Presidential Lecture: The State of Liver Disease in South Asia: What are we doing about it? | Dr. Saeed Hamid, President SAASL |
State of the Art Lecture: Eradication of HCV: Myth or Reality | Dr. Wasim Jafri, Patron PSSLD |
DAA and common drug interactions. | Dr. Masood Siddiq, President PSSLD |
NAFLD related Cirrhosis in Diabetic- Therapeutic options | Dr. Zaigham Abbas, Vice President PSSLD |
Monitoring surrogates of HBV: DNA/ mRNA/ qHBsAg | Dr. Lubna Kamani |
Exercise and Dietary intervention in NAFLD: How to be precise? | Dr. Om Parkash |
Decompensated HCV Cirrhosis: Have DAAs Improved Transplant Free Survival? | Dr. Amna Subhan |